title: Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
authors.forename: Hiroe
authors.initials: H
authors.lastname: Toki
authors.forename: Shigeki
authors.initials: S
authors.lastname: Momohara
authors.forename: So
authors.initials: S
authors.lastname: Tsukahara
authors.forename: Katsunori
authors.initials: K
authors.lastname: Ikari
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab